DE69332259T2 - Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung - Google Patents
Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren VerwendungInfo
- Publication number
- DE69332259T2 DE69332259T2 DE69332259T DE69332259T DE69332259T2 DE 69332259 T2 DE69332259 T2 DE 69332259T2 DE 69332259 T DE69332259 T DE 69332259T DE 69332259 T DE69332259 T DE 69332259T DE 69332259 T2 DE69332259 T2 DE 69332259T2
- Authority
- DE
- Germany
- Prior art keywords
- ring
- substituted
- preparation
- thiadiazole derivatives
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6761592 | 1992-03-25 | ||
JP3087293 | 1993-02-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69332259D1 DE69332259D1 (de) | 2002-10-10 |
DE69332259T2 true DE69332259T2 (de) | 2003-07-31 |
Family
ID=26369305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332259T Expired - Fee Related DE69332259T2 (de) | 1992-03-25 | 1993-03-25 | Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung |
Country Status (5)
Country | Link |
---|---|
US (1) | US5550138A (de) |
EP (1) | EP0562599B1 (de) |
AT (1) | ATE223419T1 (de) |
CA (1) | CA2092390A1 (de) |
DE (1) | DE69332259T2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767310A (en) * | 1993-03-19 | 1998-06-16 | Merck & Co., Inc. | Phenoxyphenylacetic acid derivatives |
US5686478A (en) * | 1993-07-20 | 1997-11-11 | Merck & Co. Inc. | Endothelin antagonists |
CA2173875A1 (en) * | 1993-11-01 | 1995-05-11 | Hideyuki Saika | Endothelin receptor antagonists |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
US5559135A (en) * | 1994-09-14 | 1996-09-24 | Merck & Co., Inc. | Endothelin antagonists bearing pyridyl amides |
US5830850A (en) * | 1996-08-28 | 1998-11-03 | Mount Sinai School Of Medicine Of The City Of New York | Methods for the treatment of bone resorption disorders, including osteoporosis |
US5691153A (en) * | 1996-09-06 | 1997-11-25 | Creighton University | Genetic markers to detect high bone mass |
US5916887A (en) * | 1996-09-23 | 1999-06-29 | National Research Council Of Canada | 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
PT1183245E (pt) * | 1999-04-22 | 2007-07-12 | Lundbeck & Co As H | Antagonistas selectivos de npy (y5) |
US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US7273880B2 (en) * | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
US6222040B1 (en) * | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
EP1194421B1 (de) * | 1999-06-30 | 2005-10-12 | H. Lundbeck A/S | Selektive npy (y5) antagonisten |
US6225330B1 (en) * | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
WO2004084830A2 (en) * | 2003-03-21 | 2004-10-07 | Buck Institute | Method for treating alzheimer’s dementia |
EP1632558A1 (de) * | 2004-09-06 | 2006-03-08 | The Procter & Gamble | Zusammensetzung enthaltend ein kationisches Polymer, welches die Abscheidung auf Oberflächen erhöht |
CA2636077C (en) * | 2006-01-18 | 2012-01-03 | Amgen Inc. | Thiazole compounds as protein kinase b (pkb) inhibitors |
BRPI0709950A2 (pt) * | 2006-04-13 | 2011-08-02 | Actelion Pharmaceuticals Ltd | uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin |
CA2693473A1 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
CA2692713A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Heterocyclic modulators of pkb |
US9079866B2 (en) | 2013-02-04 | 2015-07-14 | Janssen Pharmaceutica Nv | Flap modulators |
TWI644899B (zh) | 2013-02-04 | 2018-12-21 | 健生藥品公司 | Flap調節劑 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60246389A (ja) * | 1984-05-22 | 1985-12-06 | Nippon Soda Co Ltd | 2−スルホニルイミノ−2H−1,2,4−チアジアゾロ〔2,3−a〕ピリジン誘導体及びその製造法 |
JPS6310795A (ja) * | 1986-03-25 | 1988-01-18 | Takeda Chem Ind Ltd | 選択性除草化合物 |
JPS62263185A (ja) * | 1986-05-07 | 1987-11-16 | Nippon Soda Co Ltd | チアジアゾロピリミ(トリア)ジン誘導体、その製造方法及び除草剤 |
-
1993
- 1993-03-23 US US08/039,579 patent/US5550138A/en not_active Expired - Fee Related
- 1993-03-24 CA CA002092390A patent/CA2092390A1/en not_active Abandoned
- 1993-03-25 DE DE69332259T patent/DE69332259T2/de not_active Expired - Fee Related
- 1993-03-25 EP EP93104939A patent/EP0562599B1/de not_active Expired - Lifetime
- 1993-03-25 AT AT93104939T patent/ATE223419T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5550138A (en) | 1996-08-27 |
DE69332259D1 (de) | 2002-10-10 |
ATE223419T1 (de) | 2002-09-15 |
EP0562599B1 (de) | 2002-09-04 |
EP0562599A1 (de) | 1993-09-29 |
CA2092390A1 (en) | 1993-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69332259T2 (de) | Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung | |
ATE202337T1 (de) | Cyclopropylalkansäurederivate | |
DE69420579T2 (de) | 9-HYDROXY-PYRIDO [1,2-a] PYRIMIDIN-4-ON-ETHER-DERIVATE | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
AU2337097A (en) | Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors | |
DE69705829T2 (de) | Meta-substituierte phenylsulphonamidderivate | |
WO1993000095A3 (en) | Bicyclic fibrinogen antagonists | |
GB0206860D0 (en) | Compounds | |
HUT62892A (en) | Process for producing iso-and heterocyclic compounds furnished with imidazole ring and pharmaceutical compositions comprising same as active ingredient | |
ATE150462T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung | |
ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
EP1304329A3 (de) | Pyridonkarbonsaüre Derivate und deren Verwendung als antibakterielle Wirkstoffe | |
SK1452000A3 (en) | Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists | |
EP0902018A3 (de) | 2-(Arylphenyl)amino-imidazolin-Derivate | |
HU9300202D0 (en) | Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them | |
TW252979B (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |